T73909
Abemaciclib metabolite M18
TargetMol
DESCRIPTION
Abemaciclib metabolite M18 (LSN3106729) is a potent cyclin-dependent kinase (CDK) inhibitor with antitumor properties. It has been incorporated alongside a cereblon (CRBN) ligand to develop a proteolysis-targeting chimera (PROTAC) that selectively degrades CDK4/6 [1] [2].
DETAILS
- Cas: 2704316-81-2
- Purity: 98%
- Category: Compound
- Molecular Weight: 494.54
- Molecular Formula: C25H28F2N8O
Lead Time: 4 - 5 weeks
Sign in to view pricing